Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 5, Issue 1, 2008, Pages 13-23

  Wallace, Alison M ^a   Sandford, Andrew J ^a   English, John C ^b   Burkett, Kelly M ^a   Li, Hong ^b   Finley, Richard J ^b   Müller, Nestor L ^b   Coxson, Harvey O ^a,b   Paré, Peter D ^a   Abboud, Raja T ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Alveolar macrophage; Cathepsin; Computed tomography; Matrix metalloproteinase; Pulmonary emphysema

Indexed keywords

CARBON MONOXIDE; CATHEPSIN L; CATHEPSIN S; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE EXPRESSION; GENETIC POLYMORPHISM; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG CARCINOMA; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

AGED; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 9; POLYMERASE CHAIN REACTION; PULMONARY EMPHYSEMA; RNA, NEOPLASM; SEVERITY OF ILLNESS INDEX; TUMOR CELLS, CULTURED;

EID: 38949189965     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550701817789     Document Type: Article

References (40)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Nhlbi/who global initiative for chronic obstructive lung disease (gold) workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
2. Laurell CB, Eriksson S. The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132-140.
3. Gross P, Pfitzer EA, Tolker E, Babyak MA, Kaschak M. Experimental emphysema: Its production with papain in normal and silicotic rats. Arch Environ Health 1965; 11:50-58.
4. Mittman C. Pulmonary emphysema and proteolysis. New York: Academic Press, 1972.
5. Hogg JC, Senior RM. Chronic obstructive pulmonary disease - part 2: Pathology and biochemistry of emphysema. Thorax 2002; 57:830-834.
6. Merchant RK, Schwartz DA, Helmers RA, Dayton CS, Hunninghake GW. Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am Rev Respir Dis 1992; 146:448-453.
7. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152:1666-1672.
8. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277:2002-2004.
9. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin k-deficient human macrophages. J Exp Med 2000; 192:789-799.
10. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:S29-32.
11. D'Armiento J, Dalal SS, Okada Y, Berg RA, Chada K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992; 71:955-961.
12. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 2003; 22:672-688.
13. Ishii T, Wallace AM, Zhang X, Gosselink J, Abboud RT, English JC, Pare PD, Sandford AJ. Stability of housekeeping genes in alveolar macrophages from copd patients. Eur Respir J 2006; 27:300-306.
14. Sandford AJ, Chagani T, Spinelli JJ, Pare PD. Alpha1-antitrypsin genotypes and the acute-phase response to open heart surgery. Am J Respir Crit Care Med 1999; 159:1624-1628.
15. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Pare PD. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001; 163:469-473.
16. Coxson HO, Chan IH, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med 2004; 170:748-752.
17. Coxson HO, Rogers RM, Whittall KP, D'Yachkova Y, Pare PD, Sciurba FC, Hogg JC. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 1999; 159:851-856.
18. Rogers RM, Coxson HO, Sciurba FC, Keenan RJ, Whittall KP, Hogg JC. Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery: Use of ct morphometry. Chest 2000; 118:1240-1247.
19. Coxson HO, Mayo JR, Behzad H, Moore BJ, Verburgt LM, Staples CA, Pare PD, Hogg JC. Measurement of lung expansion with computed tomography and comparison with quantitative histology. J Appl Physiol 1995; 79:1525-1530.
20. Hedlund LW, Vock P, Effmann EL. Computed tomography of the lung. Densitometric studies. Radiol Clin North Am 1983; 21:775-788.
21. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152:653-657.
22. Agresti A. Analysis of ordinal categorical data. New York: Wiley, 1984:104-119.
23. Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 2005; 172:1378-1382.
24. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, O'Connor CM. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156:240-247.
25. Imai K, Dalal SS, Chen ES, Downey R, Schulman LL, Ginsburg M, D'Armiento J. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 2001; 163:786-791.
26. Mercer BA, Kolesnikova N, Sonett J, D'Armiento J. Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J Biol Chem 2004; 279:17690-17696.
27. Churg A, Wright JL. Proteases and emphysema. Curr Opin Pulm Med 2005; 11:153-159.
28. Molet S, Belleguic C, Lena H, Germain N, Bertrand CP, Shapiro SD, Planquois JM, Delaval P, Lagente V. Increase in macrophage elastase (mmp-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005; 54:31-36.
29. Demedts IK, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos GF, Pauwels RA, Brusselle GG. Elevated mmp-12 protein levels in induced sputum from patients with copd. Thorax 2006; 61:196-201.
30. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006; 116:753-759.
31. Churg A, Wang RD, Tai H, Wang X, Xie C, Dai J, Shapiro SD, Wright JL. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 2003; 167:1083-1089.
32. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM. Functional polymorphism in the regulatory region of gelatinase b gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99:1788-1794.
33. Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 2001; 289:116-119.
34. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115:829-835.
35. Bevilacqua MP, Schleef RR, Gimbrone MA, Jr., Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986; 78:587-591.
36. Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med 1986; 163:1595-1600.
37. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Jr., Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988; 263:5797-5803.
38. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534.
39. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001; 61:7825-7829.
40. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11:569-576.